Amedisys Inc
NASDAQ:AMED

  • LAST PRICE
    96.7100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    96.1800/ 1
  • Ask / Lots
    99.9900/ 1
  • Open / Previous Close
    --- / 96.7100
  • Day Range
    ---
  • 52 Week Range
    89.5500
    98.9500
  • Volume
    3

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 6, 2024

      Show headlines and story abstract

    • 4:33PM ET on Wednesday Nov 06, 2024 by MT Newswires
      Companies Mentioned: AMED
      04:33 PM EST, 11/06/2024 (MT Newswires) -- ...

    • 4:30PM ET on Wednesday Nov 06, 2024 by Dow Jones
      Companies Mentioned: AMED
      For the Nine-Month For the Three-Month Periods Periods Ended September Ended September 30, 2023 30, 2023 ----------------------------- ------------------------ (Income) Expense (Income) Expense Certain Items Impacting Cost of Service, Inclusive of Depreciation: Clinical optimization and reorganization costs $ 282 396 Certain Items Impacting General and Administrative Expenses: Acquisition and integration costs 338 3,106 CEO transition 1,094 5,279 Merger-related expenses 4,980 25,151 Clinical optimization and reorganization costs 466 4,203 Personal care divestiture -- 525 Certain Items Impacting Total Other Income (Expense): Other (income) expense, net (includes $106,000 merger termination fee) (353) 101,838 ---- ------------------ ---- ------------------ Total $ 6,807 $ 140,498 ==== ================== === ==== ================== Net of tax $ 6,242 $ 138,884 ==== ================== === ==== ================== Diluted EPS $ 0.19 $ 4.25 ==== ================== === ==== ==================

    • 4:30PM ET on Wednesday Nov 06, 2024 by Dow Jones
      Companies Mentioned: AMED
      For the Nine-Month For the Three-Month Periods Periods Ended September Ended September 30, 2023 30, 2023 ----------------------------- ------------------------ (Income) Expense (Income) Expense Certain Items Impacting Cost of Service, Inclusive of Depreciation: Clinical optimization and reorganization costs $ 282 396 Certain Items Impacting General and Administrative Expenses: Acquisition and integration costs 338 3,106 CEO transition 1,094 5,279 Merger-related expenses 4,980 25,151 Clinical optimization and reorganization costs 466 4,203 Personal care divestiture -- 525 Certain Items Impacting Total Other Income (Expense): Other (income) expense, net (includes $106,000 merger termination fee) (353) 101,838 ---- ------------------ ---- ------------------ Total $ 6,807 $ 140,498 ==== ================== === ==== ================== Net of tax $ 6,242 $ 138,884 ==== ================== === ==== ================== Diluted EPS $ 0.19 $ 4.25 ==== ================== === ==== ==================

Peers Headlines